SI1200070T1 - Ambroxol-containing lozenge - Google Patents

Ambroxol-containing lozenge

Info

Publication number
SI1200070T1
SI1200070T1 SI200030189T SI200030189T SI1200070T1 SI 1200070 T1 SI1200070 T1 SI 1200070T1 SI 200030189 T SI200030189 T SI 200030189T SI 200030189 T SI200030189 T SI 200030189T SI 1200070 T1 SI1200070 T1 SI 1200070T1
Authority
SI
Slovenia
Prior art keywords
tablet
ambroxol
pressing
containing lozenge
amobroxol
Prior art date
Application number
SI200030189T
Other languages
English (en)
Slovenian (sl)
Inventor
Frieder M�RZ
Der Heydt Holger Hans-Hermann Von
Horst Schmitt
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7914872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1200070(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of SI1200070T1 publication Critical patent/SI1200070T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dry Formation Of Fiberboard And The Like (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Fats And Perfumes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cosmetics (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
SI200030189T 1999-07-20 2000-07-07 Ambroxol-containing lozenge SI1200070T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19933148A DE19933148A1 (de) 1999-07-20 1999-07-20 Ambroxolhaltige Lutschtablette
PCT/EP2000/006437 WO2001005378A1 (fr) 1999-07-20 2000-07-07 Pastille a sucer contenant de l'ambroxol

Publications (1)

Publication Number Publication Date
SI1200070T1 true SI1200070T1 (en) 2003-12-31

Family

ID=7914872

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030189T SI1200070T1 (en) 1999-07-20 2000-07-07 Ambroxol-containing lozenge

Country Status (33)

Country Link
US (1) US6663889B1 (fr)
EP (2) EP1200070B1 (fr)
JP (1) JP3776041B2 (fr)
KR (1) KR100743846B1 (fr)
CN (1) CN1164263C (fr)
AT (1) ATE246493T1 (fr)
AU (1) AU776906B2 (fr)
BG (1) BG65503B1 (fr)
BR (1) BRPI0012553B8 (fr)
CA (1) CA2379314C (fr)
CZ (1) CZ301981B6 (fr)
DE (2) DE19933148A1 (fr)
DK (1) DK1200070T3 (fr)
EA (1) EA004044B1 (fr)
EE (1) EE04797B1 (fr)
ES (1) ES2173823T3 (fr)
HK (1) HK1045946B (fr)
HR (1) HRP20020050B1 (fr)
HU (1) HU229040B1 (fr)
IL (2) IL147261A0 (fr)
ME (1) MEP36808A (fr)
MX (1) MXPA02000546A (fr)
NO (1) NO331306B1 (fr)
NZ (1) NZ516987A (fr)
PL (1) PL197175B1 (fr)
PT (1) PT1200070E (fr)
RS (1) RS50246B (fr)
SI (1) SI1200070T1 (fr)
SK (1) SK284290B6 (fr)
TR (1) TR200200106T2 (fr)
UA (1) UA73313C2 (fr)
WO (1) WO2001005378A1 (fr)
ZA (1) ZA200200384B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
DE102005018561A1 (de) * 2005-04-21 2006-11-02 Giesecke & Devrient Gmbh Verfahren zum Betreiben eines Systems mit einem tragbaren Datenträger und einem Endgerät
DE102010009369A1 (de) 2010-02-25 2011-08-25 Boehringer Ingelheim International GmbH, 55218 Kindergesicherte Verpackung für Ambroxolhaltige Lutschtabletten
AU2011347257A1 (en) 2010-12-23 2013-05-23 Lectio Pharmaentwicklungs- Und Verwertungs Gmbh Aqueous solution of ambroxol
ES2864774T3 (es) 2011-12-22 2021-10-14 Centogene Ip Gmbh Combinación de un compuesto que tiene la capacidad de reorganizar una enzima lisosomal y Ambroxol y/o un derivado de Ambroxol
CN115607531A (zh) 2016-11-14 2023-01-17 王明武 用于治疗眼表疾病的制剂
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (de) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen
DE3432411A1 (de) * 1983-09-17 1985-04-11 Dr. Karl Thomae Gmbh, 7950 Biberach Antiadhaesive prohylactica und arzneimittel, enthaltend ein sekretolytisch wirksames benzylaminderivat
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt

Also Published As

Publication number Publication date
DE50003209D1 (de) 2003-09-11
TR200200106T2 (tr) 2002-07-22
CA2379314C (fr) 2007-09-11
EP1352646A2 (fr) 2003-10-15
HUP0202021A3 (en) 2004-05-28
DK1200070T3 (da) 2003-10-06
NZ516987A (en) 2003-08-29
MXPA02000546A (es) 2002-07-30
DE19933148A1 (de) 2001-01-25
JP3776041B2 (ja) 2006-05-17
IL147261A0 (en) 2002-08-14
UA73313C2 (uk) 2005-07-15
EP1352646A3 (fr) 2004-01-07
SK284290B6 (sk) 2005-01-03
CN1364075A (zh) 2002-08-14
MEP36808A (en) 2011-02-10
NO20020274L (no) 2002-03-13
CN1164263C (zh) 2004-09-01
ATE246493T1 (de) 2003-08-15
BR0012553B1 (pt) 2014-05-27
KR20020012316A (ko) 2002-02-15
ES2173823T1 (es) 2002-11-01
PT1200070E (pt) 2003-12-31
PL352276A1 (en) 2003-08-11
AU776906B2 (en) 2004-09-23
EE04797B1 (et) 2007-04-16
US6663889B1 (en) 2003-12-16
EA004044B1 (ru) 2003-12-25
NO20020274D0 (no) 2002-01-18
JP2003522125A (ja) 2003-07-22
HUP0202021A2 (hu) 2002-11-28
ES2173823T3 (es) 2004-04-16
BG106316A (en) 2002-08-30
BR0012553A (pt) 2002-04-16
HRP20020050A2 (en) 2003-06-30
EP1200070A1 (fr) 2002-05-02
KR100743846B1 (ko) 2007-08-02
HRP20020050B1 (en) 2004-06-30
EE200200027A (et) 2003-04-15
AU6269900A (en) 2001-02-05
HK1045946A1 (en) 2002-12-20
CZ20014633A3 (cs) 2002-03-13
EP1200070B1 (fr) 2003-08-06
RS50246B (sr) 2009-07-15
BRPI0012553B8 (pt) 2021-05-25
HU229040B1 (en) 2013-07-29
SK812002A3 (en) 2002-06-04
CZ301981B6 (cs) 2010-08-25
ZA200200384B (en) 2002-10-30
NO331306B1 (no) 2011-11-21
EA200200091A1 (ru) 2002-06-27
BG65503B1 (bg) 2008-10-31
PL197175B1 (pl) 2008-03-31
CA2379314A1 (fr) 2001-01-25
YU3802A (sh) 2004-09-03
IL147261A (en) 2006-12-31
HK1045946B (zh) 2005-01-28
WO2001005378A1 (fr) 2001-01-25

Similar Documents

Publication Publication Date Title
HRP20020050B1 (en) Ambroxol-containing lozenge
EP1040827A3 (fr) Utilisation de 3,4-dihydroxy-2-hydroxyméthylepyrrolidine pour le traitement du diabète
WO1995017156A3 (fr) Substitues d'ethanol
AU2034395A (en) Composition consisting of a dendrimer and an active substance occluded in the dendrimer, a process for the preparation of such a composition and a process for releasing the active substance
AU2567995A (en) Medicament chamber in an inhalation apparatus
DK0996653T3 (da) Phenolresin til limsammensætning, fremgangsmåde til fremstilling deraf og limsammensætning indeholdende den
EP1433583A4 (fr) Materiau amortisseur pour pressage a chaud et processus de production de celui-ci
AU7525498A (en) Interactive system for substance presentation and elimination
AU2001235595A1 (en) 4-heteroaryl-1,4-diazabicyclo(3.2.2)nonane, preparation and therapeutic use thereof
EP0901796A3 (fr) Dispositif d'encapsulation
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
WO2001026638A3 (fr) Utilisation du baclofene pour traiter le syndrome du sevrage de l'alcool et pour favoriser l'abstinence chez les alcooliques
WO2001083398A3 (fr) Systeme destine a la liberation d'agents actifs
NZ335078A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
AU2001259295A1 (en) Method and composition for rapid delivery of bioactive compounds to the systemiccirculation via the nasal membrane
WO2002057313A8 (fr) Composes de liaison et procedes d'identification de ces derniers
MX9602321A (es) Adhesivos de uretano de curado en humedad que contienen -butirolactona.
WO2004006831A3 (fr) Methode et dispositif d'induction de processus biologiques par des micro-organismes
WO2002005200A8 (fr) Procede, appareil et composition utilises pour personnaliser le melange de parfums
AU1411200A (en) Novel physiologically active substance, process for producing the same and utilization thereof
WO1999051544A3 (fr) Corps moule poreux de forme stable
AU5848400A (en) Novel physiologically active substance, process for producing the same and use thereof
WO2001032201A3 (fr) Composition pharmaceutique a permeabilite de membranes cellulaires elevee
WO2003004380A3 (fr) Emballage d'un solide
TW272958B (en) A manufacturing method for making re-enforced composite construction panel